Skip to main content
Clinical Trials/NCT04681937
NCT04681937UnknownNot Applicable

Clinical and Radiological Comparison of the Efficacy of Hyaluronic Acid, PRP and Steroid Injections in Partial Rotator Cuff Tears: A Prospective Randomized Study

Bezmialem Vakif University1 site in 1 country80 target enrollmentStarted: June 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
80
Locations
1
Primary Endpoint
American Shoulder and Elbow Surgeons Shoulder Score (ASES)

Study Overview

Brief Summary

There are many conservative treatment options available for partial rotator cuff tears. However, the superiority of a certain type of injection could not be demonstrated with the available data. Our aim is to compare the effectiveness of steroid, hyaluronic acid, prp and placebo (normal saline) injections in partial rotator cuff tears by applying the same physical therapy protocol after injection.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •persistent continous pain at least 3 months
  • •partial thickness rotator cuff tear on MRI

Exclusion Criteria

  • •inflammatory disease
  • •pregnancy
  • •known malignancy
  • •bleeding disorder ( or <10 g/dl Hb level, <150.000 ul platelet)
  • •previous shoulder injection
  • •history of shoulder surgery
  • •full-thickness tear
  • •other shoulder problem (osteoarthritis, bony lesions, etc)

Arms & Interventions

Hyaluronic Acid + Physical Therapy

Experimental

4 ml hyaluronic acid (subacromial)

Intervention: Subacromial Injection (hyaluronic acid) + Physical Therapy. (Combination Product)

Platelet-Rich-Plasma (PRP) + Physical Therapy

Experimental

4 ml platelet-rich-plasma (subacromial)

Intervention: Subacromial Injection (Platelet-Rich-Plasma) + Physical Therapy. (Combination Product)

Steroid + Physical Therapy

Experimental

methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) (subacromial)

Intervention: Subacromial Injection (methylprednisolone acetate) + Physical Therapy. (Combination Product)

Placebo (serum saline) + Physical Therapy

Experimental

4 ml serum saline (subacromial)

Intervention: Subacromial Injection (Serum Saline) + Physical Therapy. (Combination Product)

Outcomes

Primary Outcomes

American Shoulder and Elbow Surgeons Shoulder Score (ASES)

Time Frame: 12 months after injection

minimum score:0, maximum score:100, 100 is better function.

Secondary Outcomes

  • Constant-Murley Shoulder Outcome Score (CMS)(12 months after injection)
  • Subjective Shoulder Value (SSV)(12 months after injection)
  • Visual analogue scale (VAS)(12 months after injection)
  • Range of Motion (ROM)(12 months after injection)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Muzaffer Ağır

MD

Bezmialem Vakif University

Study Sites (1)

Loading locations...

Similar Trials